Hussman Strategic Advisors Inc. Purchases Shares of 210,000 Amprius Technologies, Inc. $AMPX

Key Points

• Hussman Strategic Advisors bought a new Q4 stake of 210,000 shares of Amprius (NYSE:AMPX) valued at about $1.657 million, representing roughly 0.16% of the company at period end.
• Insiders sold 2,539,829 shares over the last three months (≈$42.3M), including notable sales by the CTO and a director, though company insiders still own about 12.90% of the stock.
• Amprius beat quarterly estimates with EPS of -$0.01 and revenue of $25.23M but remains unprofitable with negative margins and FY2026 guidance of -0.060 EPS; analysts give a consensus "Moderate Buy" rating and a $19.75 price target while the stock trades near $20.83 (market cap ≈ $2.85B).

Hussman Strategic Advisors Inc. purchased a new stake in Amprius Technologies, Inc. (NYSE:AMPX - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 210,000 shares of the company's stock, valued at approximately $1,657,000. Hussman Strategic Advisors Inc. owned 0.16% of Amprius Technologies at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. Quarry LP bought a new position in Amprius Technologies in the 3rd quarter valued at $42,000. Jones Financial Companies Lllp boosted its holdings in Amprius Technologies by 353.2% in the 3rd quarter. Jones Financial Companies Lllp now owns 4,532 shares of the company's stock valued at $50,000 after purchasing an additional 3,532 shares during the period. Parallel Advisors LLC bought a new position in Amprius Technologies in the 3rd quarter valued at $54,000. Geneos Wealth Management Inc. bought a new position in Amprius Technologies in the 3rd quarter valued at $74,000. Finally, Cambridge Financial Group LLC bought a new position in Amprius Technologies in the 4th quarter valued at $78,000. 5.04% of the stock is owned by institutional investors.

Insider Buying and Selling at Amprius Technologies

In other Amprius Technologies news, CTO Constantin Ionel Stefan sold 25,366 shares of the business's stock in a transaction on Monday, February 23rd. The shares were sold at an average price of $10.16, for a total value of $257,718.56. Following the completion of the sale, the chief technology officer directly owned 723,330 shares of the company's stock, valued at $7,349,032.80. The trade was a 3.39% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Wen Hsuan Hsieh sold 413,146 shares of the business's stock in a transaction dated Thursday, March 12th. The shares were sold at an average price of $18.44, for a total transaction of $7,618,412.24. Following the completion of the transaction, the director owned 44,444 shares in the company, valued at $819,547.36. The trade was a 90.29% decrease in their position. The SEC filing for this sale provides additional information. Over the last three months, insiders sold 2,539,829 shares of company stock valued at $42,323,376. Company insiders own 12.90% of the company's stock.

Amprius Technologies Stock Down 1.1%

Amprius Technologies stock opened at $20.83 on Friday. The company has a market capitalization of $2.85 billion, a PE ratio of -61.27 and a beta of 2.21. The firm has a fifty day simple moving average of $16.95 and a two-hundred day simple moving average of $13.10. Amprius Technologies, Inc. has a twelve month low of $2.16 and a twelve month high of $22.80.

Amprius Technologies (NYSE:AMPX - Get Free Report) last posted its quarterly earnings results on Wednesday, March 4th. The company reported ($0.01) earnings per share for the quarter, topping the consensus estimate of ($0.04) by $0.03. The business had revenue of $25.23 million during the quarter, compared to the consensus estimate of $22.91 million. Amprius Technologies had a negative net margin of 60.30% and a negative return on equity of 24.29%. Amprius Technologies has set its FY 2026 guidance at --0.060 EPS. As a group, equities analysts expect that Amprius Technologies, Inc. will post -0.03 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several brokerages have commented on AMPX. Cantor Fitzgerald raised their price target on shares of Amprius Technologies from $16.00 to $20.00 and gave the company an "overweight" rating in a report on Friday, March 6th. Weiss Ratings reaffirmed a "sell (e+)" rating on shares of Amprius Technologies in a report on Monday, April 20th. B. Riley Financial lifted their price objective on shares of Amprius Technologies from $16.00 to $22.00 and gave the stock a "buy" rating in a report on Monday, March 9th. William Blair reaffirmed an "outperform" rating on shares of Amprius Technologies in a report on Friday, March 6th. Finally, Needham & Company LLC reaffirmed a "buy" rating and set a $20.00 price objective on shares of Amprius Technologies in a report on Tuesday, March 10th. Eight analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $19.75.

Amprius Technologies Profile

Amprius Technologies, Inc NYSE: AMPX is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company's batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.

At the core of Amprius' product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.